Clinical Commander

All dossiers
ent.tmd.core.v1

Temporomandibular disorders (DC/TMD axis-I/II — conservative-first; AGAINST irreversible occlusal therapy)

general_internal_medicinechronicsubacuteadultgeriatricoutpatient

Chronic outpatient engine for adult musculoskeletal TMD per DC/TMD axis-I + axis-II (Schiffman 2014) and AAOP 2024 commentary aligned. Two jobs: (A) confirm DC/TMD axis-I diagnosis (myalgia / arthralgia / disc displacement / DJD) and rule out red-flag mimics (GCA in older adults, ACS, head/neck malignancy, trigeminal neuralgia, intracranial); (B) run conservative-first ladder — education + self-management + OTC analgesia → supervised PT + CBT (CBT + biofeedback / relaxation = highest NMA effect) → stabilisation splint OPTION (low-certainty Cochrane) → intra-articular CS / hyaluronate for refractory arthralgia / DJD → arthrocentesis / arthroscopy / open arthroplasty for confirmed mechanical lock or end-stage. AGAINST irreversible occlusal therapy (occlusal adjustment, orthognathic surgery) as routine treatment. RxCUI status (RxNav-verified live 2026-05-26, ingredient TTY confirmed): ibuprofen 5640, naproxen 7258, acetaminophen 161, tizanidine 57258, cyclobenzaprine 21949, triamcinolone 10759, hyaluronate 62372. Stabilisation splint, PT, CBT, arthrocentesis, arthroscopy, and irreversible-occlusal-therapy-avoidance are non-pharm entries (procedure / decision / restriction; no dispensed-drug RxCUI required). PMID status (live PubMed-verified 2026-05-26): 24482784 = Schiffman DC/TMD axis-I + axis-II J Oral Facial Pain Headache 2014 (sensitivity ≥0.86, specificity ≥0.98 for common pain-related TMD); 14973990 = Al-Ani Cochrane 2004 stabilisation splint (insufficient evidence either way — encoded as OPTION); 38101924 = Yao BMJ 2023 network meta-analysis (CBT + biofeedback / relaxation RD 36% MID pain relief — highest of all interventions; jaw mobilisation 36%; manual trigger-point therapy 32%; physical-function: jaw exercise + stretching RD 43%, manipulation RD 43%, acupuncture RD 42%, jaw exercise + mobilisation RD 36%). Key clinical anchors: (1) DC/TMD axis-I has excellent diagnostic performance (sens ≥0.86, spec ≥0.98) for myalgia and the most common intra-articular disorder; (2) Yao BMJ 2023 NMA places CBT + biofeedback / relaxation at the top — coherent with axis-II priority; (3) Al-Ani Cochrane 2004 — stabilisation splint is OPTION not strong recommendation; (4) AAOP 2024 commentary aligned — AGAINST irreversible occlusal therapy; (5) GCA is a vision-saving emergency in older adults with new jaw claudication — must not be missed. Clinical-uncertainty notes: (1) Stabilisation splint has low-certainty evidence; many TMD patients arrive with prior splint therapy and unclear benefit. (2) Pharmacotherapy options (NSAID, muscle relaxant, intra-articular CS, hyaluronate) all have limited high-quality RCT data — encoded with safety counselling. (3) Pregnancy: NSAID avoid 3rd trimester; acetaminophen safer; PT + CBT + heat/cold are pregnancy-safe. (4) Trigger-point injection / acupuncture / botulinum toxin are emerging options with mixed evidence; outside the core ladder. (5) Terminology codes are canonical adult TMD ICD-10-CM but ⚠ per memory terminology pipeline is partial — flagged for scripts/terminology revalidation.

Entry points (5)

  • symptom
    Chronic jaw / preauricular / temple / temporal pain ± TMJ click / crepitus / limited opening — TMD entry per DC/TMD axis-I (Schiffman J Oral Facial Pain Headache PMID 24482784)
    jaw_pain_or_facial_pain_chronic
  • symptom
    TMJ clicking / popping / crepitus / locking / catching during jaw movement — disc derangement / DJD entry (Schiffman PMID 24482784)
    tmj_click_crepitus_locking
  • symptom
    Decreased maximum mouth opening (<40 mm), deviation or deflection on opening — functional-limitation entry; DC/TMD axis-I disc displacement with limited opening or DJD
    limited_mouth_opening_dysfunction
  • symptom
    Jaw pain with red-flag features (age ≥50 + claudication on chewing + headache + ESR/CRP for GCA, exertional cardiac, unilateral persistent + neck mass) — recognise and route OUT
    tmd_with_red_flag_features_for_screening
  • history
    Jaw pain with widespread pain (fibromyalgia phenotype), high pain-related disability, anxiety / depression — DC/TMD axis-II comorbidity entry; CBT priority (Schiffman PMID 24482784; Yao BMJ 2023 PMID 38101924)
    tmd_pain_with_widespread_pain_or_psychiatric_comorbidity

Required inputs (15)

  • pain_location_quality_severityrequired
    symptom • used at ENTRY
    DC/TMD axis-I requires preauricular / temple / masticatory muscle pain quality + triggered/modulated by jaw movement/function/parafunction — the core diagnostic feature (Schiffman J Oral Facial Pain Headache PMID 24482784)
  • pain_duration_chronicityrequired
    symptom • used at CONTEXT
    Acute (<3 mo) TMD often resolves with self-management alone; chronic (≥3 mo) drives the CBT + comprehensive management decision (Schiffman PMID 24482784)
  • jaw_function_max_opening_deviation_deflectionrequired
    symptom • used at INITIAL_WORKUP
    Maximum unassisted opening, deviation (S-curve corrected at end), or deflection (uncorrected to side of joint) during opening — disc displacement with vs without reduction, with vs without limited opening (DC/TMD axis-I Schiffman PMID 24482784)
  • tmj_click_crepitus_lockingrequired
    symptom • used at INITIAL_WORKUP
    Click on opening/closing = disc displacement with reduction; absent click + limited opening + corrective deflection toward affected side = disc displacement WITHOUT reduction (lock); crepitus = degenerative joint disease (DC/TMD axis-I Schiffman PMID 24482784)
  • masticatory_muscle_tendernessrequired
    symptom • used at INITIAL_WORKUP
    Tenderness on palpation of masseter / temporalis / lateral pterygoid is the core finding of myalgia / myofascial pain (DC/TMD axis-I — sensitivity ≥0.86 / specificity ≥0.98 for myalgia)
  • tmj_arthralgia_capsule_palpation_tendernessrequired
    symptom • used at INITIAL_WORKUP
    Tenderness on palpation of TMJ capsule / preauricular / intra-auricular finger = TMJ arthralgia; combined with crepitus suggests DJD (DC/TMD axis-I Schiffman PMID 24482784)
  • parafunctional_habits_bruxism_clenching_nail_gumrequired
    history • used at CONTEXT
    Awake or sleep bruxism, clenching, nail-biting, gum-chewing — modifiable drivers of myalgia / arthralgia; self-management foundation (Schiffman PMID 24482784 DC/TMD axis-II)
  • psychiatric_comorbidity_anxiety_depression_somatic_distressrequired
    history • used at CONTEXT
    Anxiety / depression / somatic symptom distress / high pain-related disability — DC/TMD axis-II domain; CBT priority and prognostic for chronification (Schiffman PMID 24482784; Yao BMJ 2023 PMID 38101924 — CBT + biofeedback/relaxation highest effect size)
  • widespread_pain_fibromyalgia_phenotype
    history • used at CONTEXT
    Widespread pain (fibromyalgia, chronic widespread pain phenotype) is comorbid in many TMD patients and changes management (centralised pain pathway, multimodal incl. CBT, possibly low-dose TCA/SNRI, NOT additional procedures) (Yao BMJ 2023 PMID 38101924)
  • red_flag_age_50_plus_jaw_claudication_headache_visual_changerequired
    symptom • used at RED_FLAGS
    Age ≥50 + jaw claudication on chewing + headache / scalp tenderness / visual change + elevated ESR/CRP — GIANT-CELL ARTERITIS, vision-threatening rheumatologic emergency; high-dose corticosteroid and urgent rheumatology (clinical)
  • red_flag_exertional_jaw_pain_cardiacrequired
    symptom • used at RED_FLAGS
    Exertional jaw pain without local jaw findings + cardiac risk factors — recognise ACS / angina referred pain; route OUT to cardio (clinical)
  • red_flag_unilateral_persistent_pain_mass_lymphadenopathy_b_symptomsrequired
    symptom • used at RED_FLAGS
    Unilateral persistent pain + ipsilateral mass / lymphadenopathy / weight loss / night sweats — head/neck malignancy work-up (clinical)
  • red_flag_paroxysmal_lancinating_trigger_zone_trigeminal_neuralgia
    symptom • used at DIFFERENTIAL
    Paroxysmal lancinating electric-shock-like facial pain in V2/V3 distribution with cutaneous trigger zone — trigeminal neuralgia (carbamazepine first-line); different pathway (clinical)
  • pregnancy
    history • used at TREATMENT
    Pregnancy gates NSAID safety (avoid 3rd trimester) and intra-articular CS / hyaluronate decisions; lifestyle + heat/cold + PT + CBT are pregnancy-safe foundations
  • imaging_only_for_refractory_or_red_flag
    imaging • used at BRANCHING_WORKUP
    DC/TMD diagnostic criteria do NOT require routine imaging; CT / cone-beam CT / MRI reserved for refractory cases / atypical features / suspicion of DJD-stage-IV / pre-surgical planning (Schiffman PMID 24482784)

12-phase flow (12)

  1. 1FRAME
    Frame as a CHRONIC outpatient engine for adult musculoskeletal TMD per DC/TMD axis-I + axis-II (Schiffman 2014 PMID 24482784) plus AAOP 2024 commentary. Two jobs: (A) confirm TMD diagnosis (myalgia / arthralgia / disc displacement / DJD) and rule out red-flag mimics (GCA, ACS, head/neck malignancy, trigeminal neuralgia, intracranial); (B) run conservative-first ladder — education + self-management + PT + CBT + stabilisation splint (option) + intra-articular for refractory + arthrocentesis for lock — AGAINST irreversible occlusal therapy as routine treatment.
    advance: TMD scope confirmed; red-flag mimics flagged for routing
  2. 2ENTRY
    Capture pain location (preauricular / temple / masticatory), quality + jaw-movement modulation, click / crepitus / locking, limited-opening complaint. DC/TMD requires pain triggered or modulated by jaw movement / function / parafunction (Schiffman PMID 24482784).
    inputs: pain_location_quality_severity
    advance: DC/TMD axis-I pain pattern + functional features recorded
  3. 3CONTEXT
    Build the context: chronicity (acute <3 mo vs chronic ≥3 mo — CBT priority), parafunctional habits (bruxism / clenching / nail-biting / gum), psychiatric comorbidity (anxiety / depression / somatic distress — axis-II), widespread pain / fibromyalgia phenotype, pregnancy. These drive the personalised ladder choice.
    inputs: pain_duration_chronicity, parafunctional_habits_bruxism_clenching_nail_gum, psychiatric_comorbidity_anxiety_depression_somatic_distress, widespread_pain_fibromyalgia_phenotype
    advance: chronicity + parafunction + psychosocial + widespread-pain context captured
  4. 4RED_FLAGS
    Recognise can't-miss mimics — DO NOT manage here. Age ≥50 + jaw claudication + headache / scalp tenderness / visual change + raised ESR/CRP → GIANT-CELL ARTERITIS, vision-saving emergency, urgent rheumatology + high-dose corticosteroid. Exertional jaw pain without local findings + cardiac risk → ACS / angina, route to cardio. Unilateral persistent jaw pain + mass / ipsilateral lymphadenopathy / B symptoms → head/neck malignancy work-up. Severe new headache + neuro signs → intracranial pathway.
    inputs: red_flag_age_50_plus_jaw_claudication_headache_visual_change, red_flag_exertional_jaw_pain_cardiac, red_flag_unilateral_persistent_pain_mass_lymphadenopathy_b_symptoms
    actions: panel.inflammation, panel.cbc
    advance: red-flag screen completed; GCA / ACS / malignancy / intracranial mimics routed OUT if positive
  5. 5INITIAL_WORKUP
    DC/TMD axis-I clinical exam (Schiffman PMID 24482784) — sensitivity ≥0.86 / specificity ≥0.98 for the common pain-related TMD: jaw range-of-motion (assisted + unassisted maximum opening, lateral excursions, protrusion); palpation of masseter / temporalis / lateral pterygoid / TMJ capsule; auscultation for click / crepitus during opening / closing / lateral excursion. Axis-II screening: pain intensity NRS, pain-related disability, psychological distress, jaw functional limitations, parafunctional behaviours — 41-question screening or 81-question comprehensive set. Routine bloods NOT required for primary TMD; ESR/CRP only if GCA suspicion.
    inputs: jaw_function_max_opening_deviation_deflection, tmj_click_crepitus_locking, masticatory_muscle_tenderness, tmj_arthralgia_capsule_palpation_tenderness
    actions: panel.inflammation
    advance: axis-I clinical exam complete; axis-II psychosocial screen completed; DC/TMD diagnosis assigned
  6. 6BRANCHING_WORKUP
    Branch only when atypical or refractory: CT or cone-beam CT for DJD staging; MRI TMJ for disc-displacement-with-lock pre-surgical planning; rheumatologic work-up for inflammatory arthritis (RA, psoriatic, AS); routine imaging NOT recommended for typical pain-related TMD (Schiffman PMID 24482784).
    inputs: imaging_only_for_refractory_or_red_flag
    advance: atypical / refractory cases imaged appropriately; typical pain-related TMD does NOT need imaging
  7. 7DIFFERENTIAL
    Terminal differential (DC/TMD + clinical): myalgia / myofascial pain (muscle palpation tenderness pivot) vs arthralgia (TMJ capsule tenderness pivot) vs disc displacement with reduction (click pivot) vs disc displacement WITHOUT reduction with limited opening (closed lock, no click, deflection pivot) vs DJD (crepitus + radiographic pivot) vs trigeminal neuralgia (paroxysmal lancinating + V2/V3 + trigger zone pivot — different pathway, carbamazepine) vs GCA (age + claudication + ESR/CRP pivot — emergency, route OUT) vs head/neck malignancy (mass / lymphadenopathy / B symptoms pivot — biopsy pathway) vs cardiac referred pain (exertional + cardiac risk pivot — cardio pathway) vs dental / sinus / otitis source (alternative anatomic source).
    inputs: red_flag_paroxysmal_lancinating_trigger_zone_trigeminal_neuralgia
    advance: best DC/TMD axis-I diagnosis + axis-II comorbidity profile assigned; non-TMD pathways routed OUT
  8. 8RISK_STRATIFICATION
    Stratify by chronicity + axis-II distress: acute <3 mo with low distress (most resolve with self-management alone); chronic + low distress (PT + jaw exercise + CBT optional); chronic + high distress / disability (CBT + biofeedback / relaxation HIGHEST PRIORITY per Yao BMJ 2023 PMID 38101924 — RD 36% for clinically meaningful pain relief). Layer widespread-pain phenotype (centralised pain pathway).
    inputs: pain_duration_chronicity, psychiatric_comorbidity_anxiety_depression_somatic_distress
    advance: chronicity + axis-II distress band + widespread-pain status assigned
  9. 9TREATMENT
    Conservative-first stepped ladder (Schiffman PMID 24482784 DC/TMD; Yao BMJ 2023 PMID 38101924 network meta-analysis; Al-Ani Cochrane 2004 PMID 14973990 stabilisation splint). Step 1 (ALL): education + self-management (soft diet, jaw rest, no gum, no clenching, no wide yawn), heat/cold, gentle jaw exercises, OTC NSAID or acetaminophen short course. Step 2: supervised PT (jaw exercises + stretching + manual therapy) + CBT-based interventions (CBT + biofeedback/relaxation showed RD 36% for MID pain relief, highest of all interventions per Yao BMJ 2023 NMA); manual trigger-point therapy RD 32%. Step 3 (selected): stabilisation splint (NOT repositioning splint) for bruxism / myalgia — low-certainty Cochrane evidence, OPTION not strong recommendation. Step 4 (arthralgia / DJD refractory): intra-articular triamcinolone or hyaluronate. Step 5 (refractory disc-displacement lock or end-stage DJD): arthrocentesis / arthroscopy / open arthroplasty (last resort). AGAINST IRREVERSIBLE OCCLUSAL THERAPY (occlusal adjustment, orthognathic surgery for routine TMD).
    inputs: parafunctional_habits_bruxism_clenching_nail_gum, pregnancy
    advance: appropriate ladder step started; CBT prioritised for chronic + high-distress; irreversible occlusal therapy explicitly avoided
  10. 10DISPOSITION
    OUTPATIENT longitudinal management is the default — primary care + dentistry / orofacial-pain specialist + physical therapy + psychology / mental health if axis-II distress prominent. Maxillofacial surgery referral only for refractory cases with confirmed mechanical lock or end-stage DJD. GCA / ACS / malignancy / intracranial → emergency / specialist route OUT.
    inputs: red_flag_age_50_plus_jaw_claudication_headache_visual_change
    advance: outpatient multimodal team set; emergency referrals queued where indicated
  11. 11MONITORING
    Track at each 6-12-week visit (more often early): pain NRS, maximum opening, parafunction status, PT engagement, CBT module completion, NSAID / acetaminophen use, sleep / mood comorbidity. Most patients improve within 3-6 months; persistent symptoms at 6 months prompt CBT escalation, splint trial, or imaging.
    inputs: psychiatric_comorbidity_anxiety_depression_somatic_distress
    advance: structured pain + function + PT/CBT engagement + parafunction review completed each visit
  12. 12FOLLOWUP
    Longitudinal chronic-disease arc — 6-12-monthly stable; sooner for flare or worsening. Avoid scope creep into irreversible procedures (occlusal adjustment, orthognathic, total joint replacement) — counsel patient that AAOP 2024 commentary aligned is AGAINST these for routine TMD. Re-screen for axis-II distress at every visit. Maintain self-management foundation indefinitely.
    inputs: parafunctional_habits_bruxism_clenching_nail_gum
    advance: structured longitudinal + irreversible-procedure-counter-counselling + axis-II re-screen completed